01672.HK
Ascletis Pharma Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 10.09
−2.32%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 39.10x
- P/S forward
- 79.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.70x
- Price / sales
- 2540.20x
- Price / cash flow
- -25.55x
Enterprise value
- Enterprise value
- HKD 7.2B
- EV / sales
- 1856.65x
- EV / EBITDA
- -5.80x
- EV / EBIT
- -5.34x
- Market cap
- HKD 9.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026